Menu

The Human Microbiome: Colonization in Health and Disease

Join The Scientist as we navigate the human microbiome by bringing together a panel of experts to discuss how microbiota impact human health.

May 31, 2018
The Scientist Creative Services Team

The Human Microbiome: Colonization in Health and Disease from thescientistllc on Vimeo.

The moment we enter the world, we are inhabited by a plethora of microbes. This microbial colonization changes throughout our life and is impacted by where we grow up, and what we touch, eat, and experience. Events like a fever or a course of antibiotics can cause sudden shifts in our microbiomes, with effects that may last for years or even a lifetime. Join The Scientist as we navigate the human microbiome by bringing together a panel of experts to discuss how microbiota impact human health. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Topics to be covered:

  • Better living through gut microbes
  • Uncovering the world of the vaginal microbiome


Meet the Speakers:

Peter Turnbaugh, PhD
Assistant Professor
Department of Microbiology and Immunology
G.W. Hooper Research Foundation
Chan Zuckerberg Biohub Investigator
University of California San Francisco

Elisabeth Bik, PhD
Scientific Editorial Director
uBiome


November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.